A detailed history of Franklin Resources Inc transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 100,795 shares of TSHA stock, worth $186,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,795
Previous 100,795 -0.0%
Holding current value
$186,470
Previous $202,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.01 - $2.46 $202,597 - $247,955
100,795 New
100,795 $202,000
Q1 2023

May 12, 2023

SELL
$0.65 - $2.3 $148 - $526
-229 Reduced 0.03%
810,840 $648,000
Q2 2022

Aug 11, 2022

SELL
$2.47 - $6.77 $1.21 Million - $3.31 Million
-489,599 Reduced 37.64%
811,069 $3.02 Million
Q1 2022

May 13, 2022

SELL
$5.22 - $11.86 $41,055 - $93,278
-7,865 Reduced 0.6%
1,300,668 $8.48 Million
Q4 2021

Feb 11, 2022

SELL
$11.43 - $19.2 $19,168 - $32,198
-1,677 Reduced 0.13%
1,308,533 $15.2 Million
Q3 2021

Nov 12, 2021

BUY
$15.82 - $21.57 $69,038 - $94,131
4,364 Added 0.33%
1,310,210 $24.4 Million
Q2 2021

Aug 13, 2021

BUY
$19.29 - $26.38 $3.6 Million - $4.92 Million
186,677 Added 16.68%
1,305,846 $27.7 Million
Q1 2021

May 13, 2021

BUY
$20.3 - $31.75 $6.49 Million - $10.1 Million
319,640 Added 39.98%
1,119,169 $22.7 Million
Q4 2020

Feb 10, 2021

SELL
$19.14 - $28.13 $18,967 - $27,876
-991 Reduced 0.12%
799,529 $21.2 Million
Q3 2020

Nov 12, 2020

BUY
$22.4 - $24.47 $17.9 Million - $19.6 Million
800,520 New
800,520 $17.9 Million

Others Institutions Holding TSHA

About Taysha Gene Therapies, Inc.


  • Ticker TSHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,359,500
  • Market Cap $89.5M
  • Description
  • Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...
More about TSHA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.